News & Insights
Notable Recent Precision Xtract Publications
The research findings of Precision Xtract’s scientific thought leaders are regularly published in top-tier journals. You can read some of our notable, recently published research at the links below.
Lorenzi M, Ambegaonkar B, Baxter CA, Jansen J, Zoratti MJ, Davies G. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Clinical Res Cardiol. 2018;9. In press.
Keeping S, Wu E, Chan K, Mojebi A, Ferrante SA, Balakumaran A. Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparison. Exp Rev Hematol. 2018;11(6):503-511.
Evans M, Billings LK, Hakan-Bloch J, Slothuus U, Abrahamsen TJ, Andersen A, Jansen JP. An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin. J Med Econ. 2018;21(4):340-347.
Sacks NC, Cyr PL, Louie AC, Liu Y, Chiarella MT, Sharma A, Chung KC. Burden of Acute Myeloid Leukemia among older, newly diagnosed patients: retrospective analysis of data from the 2010-2012 Medicare Limited Data Set. Clin Ther. 2018;40(5):692-703.
Jensen IS, Wu E, Sacks NC, Cyr PL, Chung KC. Budget impact analysis of using daunorubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and Myelodysplasia-related changes. Am Health Drug Benefits. 2018;11(7):380-386.
Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir SP. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol. 2018;11:289-299.
Discover exactly what Precision can do for you. We look forward to learning about your needs, exploring how we can support you, and sharing our proven approaches. For information and inquiries, please contact:
President and General Manager+1 240.316.3451
Larry Blandford, PharmD
Executive Vice President and Managing Partner+1 212.686.2650
J. Bruce Leavitt, MBA
Executive Vice President and Managing Partner+1 203.487.5240
Ross Maclean, MD, PHD, MBA
Executive Vice President, General Manager+1 310.984.7708